Neurocrine Biosciences
NBIX
#1320
Rank
A$25.21 B
Marketcap
A$249.14
Share price
-2.87%
Change (1 day)
10.89%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company